Sara Rothman
FDA investigator
Appears on 1 document from 2018, mostly at sites in Arkansas. Most often cites control of microbiological contamination (21 CFR 211.113(b)).
- 1
- Documents on file
- 7.0
- Observations per 483
- 2018
- First seen
- 2018
- Most recent
What they cite most
From 7 observations- 21 CFR 211.113(b)Control of microbiological contamination1
- 21 CFR 211.192Production record review1
- 21 CFR 211.198(a)Complaint files1
- 21 CFR 211.84(d)(2)Testing and approval or rejection of components, drug product containers, and closures1
- 21 CFR 310.305Records and reports concerning adverse drug experiences on marketed prescription drugs for human use without approved new drug applications1
Activity by year
2018: 1
Where
Arkansas 1
Often inspects with
Is Sara Rothman coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2018-03-22 | 483 Cantrell Drug CompanyMar 22, 2018 · Little Rock, Arkansas | Little Rock, Arkansas | 7 |
About this profile
What does Sara Rothman inspect?
Sara Rothman appears on 1 document on file covering 1 site, mostly in Arkansas.
What do they cite most often?
21 CFR 211.113(b) (control of microbiological contamination), followed by 21 CFR 211.192 and 21 CFR 211.198(a).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Sara Rothman is dated Mar 22, 2018.